Cannabis Science Inc.
Cannabis Science Inc.
Home
About Us
Corporate Overview
Mission Statement
Cannabis Science Team
Careers & Corporate Culture
iCannabinoid
Join Now!
R&D
The Science of Cannabinoids
CBIS Cannabinoid Research
Critical Ailments
COLLABORATIONS & PROJECTS
CBIS Medical Consortium
Global Economic Development
Pan African A & C University
African Economic Initiative
American States University
North American Economic Initiative
Dana-Farber
CFA
Stellenbosch University
CBIS Bottle It
Products & Pharmacies
Products
Order Online
Pharmacies
Investors
CBIS Current Share Structure
SEC Filings
Media
CBIS News Releases
CBIS In The News
CBIS Events
Contact
latest Articles
Cannabis Science Issues 2019 Guidance Report; Under SEC Sanctions the Company Goes Private as It Enters Into Step (2) of Its Growth Transition, Enabling Full Transparency and Revenue Growth
Cannabis Science Enters Transition Stage as Trading of the Company’s Shares is Halted; The Company Will Continue to Implement Its Growth Strategy and Resolve All Outstanding Fully Reporting Requirements
Cannabis Science Partners With CDN Firm NHS Industries to Launch the CBIS CDN Economic Development Plan; CBIS to Use Its Relations With the Harvard International Phytomedicines and Medical Cannabis Institute and Other Leading Institutions
Cannabis Science Prepares Announcements for Revenues and Corporate Growth; Finalizing New Asset Partnerships and Acquisitions Targeting Positive Cash Flow in Key Markets Globally
Cannabis Science Successfully Completes European Headquarters and Operations Move to The Netherlands and Completes Shut Down of All Cannabis Science Europe GmbH Germany Operations
CBIS LATEST NEWS.
Home
2010
2018
-
2017
-
2016
-
2015
-
2014
-
2013
-
2012
-
2011
-
2010
-
2009
Warning
: Creating default object from empty value in
/home/cannabisscience/public_html/plugins/system/t3/base-bs3/html/com_content/category/default_articles.php
on line
17
Title
Published Date
President Obama's Deputy Drug Czar Tom McClellan Comments in USA TODAY Article; Endorses Non-Smoked Medical Marijuana Delivery Systems Identical to the First Product Cannabis Science is Developing for FDA Clinical Trials for PTSD Targeting Our Veterans, A
10-05-10
Non-Smoked Medical Cannabis Products Needed, Says National Drug Control Policy Deputy Director
11-05-10
Cannabis Science Demonstrates That Pharmaceutical Cannabis and Medical Marijuana Are Essential to Contain Health Care Costs and Give Patients Access to Affordable and Effective Medicines Offering the Obama Administration Non-Smoked Medical Marijuana Deli
24-05-10
Cannabis Science Inc. Chosen on StockProfile.com
26-03-10
Cannabis Science Calls for Public Support for Vets as New York Times Reports VA Docs Prohibited From "Recommending" Cannabis for Post Traumatic Stress Disorder (PTSD)
21-03-10
Dr. Robert Melamede, PhD., President & CEO of Cannabis Science, Reports High Level of Media Interest in Public Speaking Engagements, News Interviews, and Corporate Sponsorships at Several Cannabis
12-04-10
Cannabis Science New Management Files First 10K Annual Report, Opens In-House Investor Relations Department in Southern Florida, and Prepares to Announce Several Expansions and Advancements for Each of Its Divisions
07-05-10
Cannabis Science Inc. Adds Online Communication Specialists in Response to an Increasing Interest in Dr. Robert Melamede's Understanding of the Amazing Role Played by the Endocannabinoid System Worldwide
12-05-10
Cannabis Science Negotiates for a 7,500 Sq. Ft., Facility in Colorado Springs to Facilitate Both Research and Revenues in the Company's Five Divisions
13-05-10
Cannabis Science Comments on Recent USA TODAY Article That The Obama Administration Refocuses Its Unsuccessful War On Drugs to a Public Health Fight and Speaks About the Growing Recognition of Marijuana for Medical Purposes
19-05-10
Start
Prev
1
2
3
4
5
Next
End